← HMB

Muscle Preservation and Recovery

How this natural leucine metabolite protects muscle during illness, aging, and recovery — and what the evidence actually shows

HMB (beta-hydroxy beta-methylbutyrate) is a small compound your body makes naturally when it breaks down leucine, an amino acid found in meat, eggs, and dairy. Most leucine goes toward building protein, but about 5% is converted to HMB — and that fraction turns out to do something different: it slows the breakdown of muscle tissue rather than building new protein. This makes HMB particularly useful in situations where muscle loss is the primary threat — illness, bed rest, aging, or aggressive calorie restriction. The research is most compelling for older adults and people with muscle-wasting conditions, and more mixed for healthy, well-trained athletes [1][3][4].

How HMB Works

HMB acts through two complementary pathways: it reduces muscle protein breakdown, and it stimulates the machinery cells use to build muscle protein.

Reducing Muscle Protein Breakdown

The primary mechanism of HMB involves inhibiting the ubiquitin-proteasome pathway — the cellular system responsible for tagging and degrading damaged or unneeded proteins. When muscles are under stress (from exercise, illness, or inactivity), this pathway becomes overactive, breaking down muscle tissue faster than it can be rebuilt. HMB downregulates key components of this system, including the E3 ubiquitin ligases MuRF1 and MAFbx (also called atrogin-1), which are the main molecular executors of muscle atrophy [2].

Separately, HMB inhibits caspase-dependent apoptosis in muscle cells. During prolonged muscle disuse or disease states, muscle cells begin to undergo programmed cell death — HMB blunts this process at physiological concentrations.

Supporting Muscle Protein Synthesis

HMB also activates mTORC1 (mechanistic target of rapamycin complex 1), the master regulator of protein synthesis in skeletal muscle. This activation occurs independently of the standard leucine/mTOR pathway, meaning HMB and leucine can have additive effects. HMB additionally upregulates IGF-1 gene expression in muscle tissue and enhances satellite cell activation — the muscle stem cells responsible for repair and adaptation after training [1][2].

Who Benefits Most

The research picture divides clearly across populations:

Older adults and those with muscle-wasting conditions show the strongest and most consistent response to HMB. With aging, muscles become less sensitive to the anabolic stimulus of protein — a phenomenon called anabolic resistance. HMB appears to partially overcome this resistance, making it more effective in older people than in younger, healthy individuals. Clinical populations with cancer, COPD, HIV, or prolonged bed rest show similar patterns [3][4].

Untrained individuals beginning a resistance program show moderate benefit. When someone is new to training, the anabolic stimulus from exercise is already high, and additional leucine metabolites push the response further. Several early trials showing impressive HMB effects were conducted in untrained or recreationally active people [1].

Well-trained athletes show little to no benefit from HMB supplementation. A 2018 meta-analysis of six RCTs in trained and competitive athletes found no significant effect on bench press, leg press, lean mass, or fat mass [5]. This is not surprising — trained athletes have already adapted their protein turnover regulation, and the marginal benefit from HMB appears insufficient to add meaningful benefit on top of an already optimized training state.

Dosage and Forms

The standard research dose is 3 grams per day, typically divided into three 1-gram doses taken with meals. This dose was established in the original 1996 trials and has been used consistently across the literature. Studies using this dose for 12 or more weeks show the most reliable outcomes.

HMB comes in two forms:

HMB-Ca (calcium salt) — the form used in most long-term research; slower absorption, steady plasma levels
HMB-FA (free acid) — faster absorption, higher peak plasma levels; some studies suggest modestly better acute performance outcomes, though long-term data is similar

HMB is classified as a dietary supplement and is generally recognized as safe. Studies using 3 g/day for up to a year have found no significant adverse effects, and cardiovascular safety markers were neutral or improved in longer trials [2].

Practical Context

HMB is not a mass-building supplement. People expecting dramatic gains comparable to creatine or protein will be disappointed. Its value is in preserving what you already have during periods of stress — a hospital stay, significant calorie restriction, prolonged illness, or the gradual muscle loss of aging (sarcopenia). If you are over 50 and concerned about maintaining muscle mass, or recovering from surgery or illness, the evidence is reasonable enough to consider 3 g/day for at least 12 weeks alongside adequate protein intake.

For otherwise healthy adults under 50 who train regularly, the evidence does not support adding HMB. Creatine has a much stronger evidence base for strength and muscle development in this population. See our creatine page for comparison, and our whey protein page for the protein context.

Evidence Review

Original Discovery: Nissen et al. 1996

The landmark paper by Nissen and colleagues (PMID 8941534), published in the Journal of Applied Physiology, established HMB as a biologically active leucine metabolite with anti-catabolic properties. Two randomized experiments were conducted in young men performing resistance training. In Experiment 1 (41 subjects, 3 weeks), participants received 0, 1.5, or 3.0 g HMB/day with either high or moderate protein. In Experiment 2 (28 subjects, 7 weeks), the 3 g dose was compared to placebo in a more intensive training program.

Key findings: urine 3-methylhistidine (a biomarker of muscle proteolysis) was significantly lower in the first two weeks of training in HMB groups, indicating reduced muscle breakdown. Plasma creatine kinase — a marker of muscle damage — was also lower. Lean mass gains were greater in the 3 g HMB group in both experiments. These early results were striking and generated substantial follow-up research, though subsequent work in trained individuals has been less impressive.

Systematic Review Across 39 Trials: Molfino et al. 2013

Molfino and colleagues (PMID 24057808) in Amino Acids conducted a comprehensive systematic review of 39 RCTs across four populations: trained athletes (13 studies), untrained healthy adults (11 studies), patients with chronic disease (9 studies), and elderly (6 studies). Their conclusion — that 3 g/day may be routinely recommended to maintain or improve muscle mass in health and disease — was based on the breadth of evidence showing consistent (if sometimes modest) benefit. For clinical populations, the benefit was clearest in those with HIV-associated wasting, cancer cachexia, and COPD. In elderly and untrained populations, lean mass and strength gains were consistent across most trials. The review noted that adverse event profiles were clean across all populations studied.

Older Adults Meta-Analysis: Wu et al. 2015

Wu and colleagues (PMID 26169182) in Archives of Gerontology and Geriatrics meta-analyzed 7 RCTs specifically in older adults, involving 287 total participants. The pooled analysis found that HMB supplementation produced significantly greater muscle mass gain compared to control (standardized mean difference = 0.352 kg; 95% CI: 0.11–0.594; P = 0.004). There was no significant effect on fat mass. The authors noted that HMB's anti-catabolic mechanism appears particularly well-suited to aging muscle, which tends to have elevated basal protein breakdown rates and blunted anabolic response to feeding. The effect size, while modest in absolute terms, is clinically meaningful for frail elderly where even small reductions in muscle loss can translate to maintained independence and reduced fall risk.

Clinical Populations: Bear et al. 2019

Bear and colleagues (PMID 30982854) at King's College London published what is currently the largest meta-analysis of HMB in clinical contexts, synthesizing 15 RCTs involving 2,137 patients with conditions including cancer, COPD, and critical illness. For muscle mass, the pooled SMD was 0.25 (95% CI: -0.00–0.50; P = 0.05) — borderline significant with small effect size. For muscle strength, the evidence was stronger: SMD = 0.31 (95% CI: 0.12–0.50; P = 0.001) with no heterogeneity. The authors noted that study quality varied, and the effect sizes were small, calling for better-designed trials in specific clinical subgroups. Importantly, they found no effect on body weight, which suggests HMB's action is genuinely muscle-compartment specific rather than a general anabolic effect.

Null Result in Athletes: Sanchez-Martinez et al. 2018

This meta-analysis (PMID 29249685) in the Journal of Science and Medicine in Sport examined six RCTs involving 193 trained or competitive athletes. Effect sizes for all outcomes — bench press, leg press, lean body mass, fat mass — were trivial and non-significant (all p > 0.05). The null result persisted across subgroup analyses by dose, duration, and training level. This is a well-designed meta-analysis and the finding should be taken seriously: HMB does not meaningfully improve strength or body composition in people who are already well adapted to training. This is not a failed supplement — it simply does not target the primary limitation in this population.

Overall Evidence Assessment

The evidence for HMB is robust in two contexts: older adults with age-related muscle loss and clinical patients with muscle-wasting conditions. Effect sizes are modest but clinically relevant, safety is well-established over decades of study, and the mechanisms are well-characterized. The evidence for healthy, younger, trained individuals is clearly negative. The appropriate use case is anti-catabolic support during high-risk periods for muscle loss, not as a mass-building supplement. The recommended dose of 3 g/day used for 12+ weeks remains the best-supported protocol.

References

Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise trainingNissen S, Sharp R, Ray M, Rathmacher JA, Rice D, Fuller JC Jr, Connelly AS, Abumrad N. Journal of Applied Physiology, 1996. PubMed 8941534 →
Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trialsMolfino A, Gioia G, Rossi Fanelli F, Muscaritoli M. Amino Acids, 2013. PubMed 24057808 →
Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysisWu H, Xia Y, Jiang J, Du H, Guo X, Liu X, Li C, Huang G, Niu K. Archives of Gerontology and Geriatrics, 2015. PubMed 26169182 →
β-Hydroxy-β-methylbutyrate and its impact on skeletal muscle mass and physical function in clinical practice: a systematic review and meta-analysisBear DE, Langan A, Dimidi E, Wandrag L, Harridge SDR, Hart N, Connolly B, Whelan K. American Journal of Clinical Nutrition, 2019. PubMed 30982854 →
Effects of beta-hydroxy-beta-methylbutyrate supplementation on strength and body composition in trained and competitive athletes: A meta-analysis of randomized controlled trialsSanchez-Martinez J, Santos-Lozano A, Garcia-Hermoso A, Sadarangani KP, Cristi-Montero C. Journal of Science and Medicine in Sport, 2018. PubMed 29249685 →